Moreover, FASN expression was decreased in the tumour tissue of FASN‐shRNA2 group, accompanied by the down‐regulation of PRRX1, cyclin D1 and c‐Myc (Figure 5B). This evidence concerns the gene PRRX1 and neoplasm.